Cargando…

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country

BACKGROUND: A heavy financial burden is imposed on patients suffering from chronic diseases due to medicine out-of-pocket payments. OBJECTIVES: This study focuses on assessing the affordability of medications used for chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fathi, Mahdieh, Moradi, Najmeh, Yousefi, Nazila, Peiravian, Farzad, Shobeiri, Nikta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625700/ https://www.ncbi.nlm.nih.gov/pubmed/37925396 http://dx.doi.org/10.1186/s12890-023-02737-5

Ejemplares similares

Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
por: Minaei, Hossein, et al.
Publicado: (2019)

How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?
por: Shobeiri, Nikta, et al.
Publicado: (2022)

Impact of the Trade-Related Aspect of Intellectual Property Rights Agreement on Pharmaceutical Industry in Developing Countries: A Scoping Review
por: Fathi, Mahdieh, et al.
Publicado: (2021)

The Effect of Organizational Resilience and Strategic Foresight on Firm Performance: Competitive Advantage as Mediating Variable
por: Fathi, Mahdieh, et al.
Publicado: (2021)

Perceptions, experiences and expectations of physicians regarding the role of pharmacists in low-income and middle-income countries: the case of Tehran hospital settings
por: Alipour, Fatemeh, et al.
Publicado: (2018)

Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings
por: Siddharthan, Trishul, et al.
Publicado: (2022)

How does external reference pricing work in developing countries: evidence from Iran
por: Babaie, Fatemeh, et al.
Publicado: (2023)

Exploring health seeking behaviors for common cold management
por: Keshvari, Negin, et al.
Publicado: (2023)

Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries
por: Kadkhodamanesh, Azin, et al.
Publicado: (2021)

The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
por: Stolbrink, Marie, et al.
Publicado: (2022)

Achieving affordable critical care in low-income and middle-income countries
por: Turner, Hugo C, et al.
Publicado: (2019)

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
por: Taheri, Saeed, et al.
Publicado: (2019)

An application of analytic network process model in supporting decision making to address pharmaceutical shortage
por: Zarei, Leila, et al.
Publicado: (2020)

Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019)

How Much Iranian Parents Know of and How Well They Practice Regarding Antibiotics?
por: Sharif, Zahra, et al.
Publicado: (2021)

An investigation into the pharmaceutical advertising in Iranian medical journals
por: Yousefi, Nazila, et al.
Publicado: (2022)

Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020)

Improving access to affordable vaccines for middle-income countries in the african region
por: Mihigo, Richard, et al.
Publicado: (2019)

Efficacy and Safety of Dulaglutide Compared to Liraglutide: A Systematic Review and Meta-analysis in Patients with Type 2 Diabetes Mellitus
por: Taheri, Saeed, et al.
Publicado: (2019)

Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
por: Atanasova, Kalina R., et al.
Publicado: (2018)

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
por: Stolbrink, M., et al.
Publicado: (2022)

Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?
por: Beck, Eduard J., et al.
Publicado: (2019)

Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country
por: Moye-Holz, Daniela, et al.
Publicado: (2017)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

Private Demand for Covid-19 Vaccine: A Contingent Assessment from a Low-and Middle-income Country
por: Meshkani, Zahra, et al.
Publicado: (2021)

Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
por: Moye-Holz, Daniela, et al.
Publicado: (2020)

Supporting more affordable and equitable cancer care and research in Lower and Middle Income Countries: ecancer’s commitment
por: Sullivan, Richard, et al.
Publicado: (2021)

Asthma management in low and middle income countries: case for change
por: Mortimer, Kevin, et al.
Publicado: (2022)

Gaps in asthma diagnosis and treatment in low- and middle-income countries
por: Barne, Monica
Publicado: (2023)

Urbanisation and asthma in low-income and middle-income countries: a systematic review of the urban–rural differences in asthma prevalence
por: Rodriguez, Alejandro, et al.
Publicado: (2019)

The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary
Publicado: (2017)

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector
por: Faust, Lena, et al.
Publicado: (2020)

The challenges of asthma care in low- and middle-income countries: what’s next?
por: Pitrez, Paulo Márcio
Publicado: (2023)

Clinical standards for the diagnosis and management of asthma in low- and middle-income countries
por: Jayasooriya, S., et al.
Publicado: (2023)

Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis
por: Knutsen, Alan P., et al.
Publicado: (2011)

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran
por: Zarei, Leila, et al.
Publicado: (2022)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

Factors associated with the availability and affordability of essential cardiovascular disease medicines in low- and middle-income countries: A systematic review
por: Lotfizadeh, Ali, et al.
Publicado: (2022)

Is quality affordable for community health systems? Costs of integrating quality improvement into close-to-community health programmes in five low-income and middle-income countries
por: Kumar, Meghan Bruce, et al.
Publicado: (2019)

Affordable stroke therapy in high-, low- and middle-income countries: From Theradrive to Rehab CARES, a compact robot gym
por: Johnson, Michelle Jillian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qlnm94mnsgcv3irp8ih1vgpac7